Modified dialectical behavior therapy-informed transdiagnostic intervention for emotional disorders: protocol for a randomized controlled trial.
Shen-Ing Liu, Chih-Hung Chang, Chen-Ju Lin...
https://pubmed.ncbi.nlm.nih.gov/39506661Actively Recruiting
Phase Not Applicable
Age: 18Years - 65Years
All Genders
ID05989451
Adaptation of Individual Dialectical Behavior Therapy Intervention for Transdiagnostic Treatment of Emotional Disorders in Two Medical Centers: a Randomized Controlled Trial
Led by Mackay Memorial Hospital · Updated on 2026-05-29
250
Participants Needed
1
Research Sites
13 weeks
Total Duration
On this page
Sponsors
M
Mackay Memorial Hospital
Lead Sponsor
N
National Science and Technology Council
Collaborating Sponsor
AI-Summary
What this Trial Is About
Anxiety and depressive disorders, collectively called emotional disorders, are common and often recur, causing significant challenges in daily functioning. Researchers are studying a modified form of Dialectical Behavior Therapy (DBT) to treat these disorders across different diagnoses. This 3-year randomized controlled trial conducted in Taiwan aims to evaluate how effective this adapted DBT is compared to usual treatments, and whether its effects vary among specific emotional disorders.
CONDITIONS
Brief Title
Adaptation of Individual Dialectical Behavior Therapy Intervention for Transdiagnostic Treatment of Emotional Disorders
Who Can Participate
Age: 18Years - 65Years
All Genders
Eligibility Criteria
You may qualify if you...
- Mandarin Chinese-language proficiency sufficient to complete study questionnaires
- Current diagnosis of depressive or anxiety disorder confirmed by clinical interview
- Age between 18 and 65 years
You will not qualify if you...
- Intellectual disability
- Substance use disorder within the past three months
- Diagnosis of bipolar disorder
- Diagnosis of psychotic disorder
- Organic brain disorder
- Acute suicidality or history of frequent or recent suicide attempts
- Recent change in psychiatric medication within six weeks or unwillingness to maintain stable medication dosage during study
- Received five or more sessions of cognitive behavioral therapy in the past five years or unwillingness to stop concurrent psychotherapy
- Any mental or physical condition requiring hospital admission
- Other medical conditions likely to prevent participation in the study
- Unwillingness to comply with study requirements or treatment protocols
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Outpatient Treatment
Duration - Approximately 15 weeks
Participants receive 15 weekly individual Dialectical Behavior Therapy (DBT) sessions, each lasting 50 to 60 minutes, targeting emotional disorders through transdiagnostic psychotherapy.
Weekly visits for up to 15 weeks
Follow-up
Duration - 12 weeks
Participants are assessed 12 weeks after completing treatment to evaluate the lasting effects of the therapy.
1 follow-up visit (in-person)
Trial Site Locations
Total: 1 location
1
MacKay Memorial Hospital
Taipei, Taiwan
Actively Recruiting
Loading map...
Research Team
H
Hui-Chun Huang, Ph.D
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here